Medication-Induced Hyperprolactinemia
Open Access
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 80 (8) , 1050-1057
- https://doi.org/10.4065/80.8.1050
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- A Randomized Open-Label Study of the Impact of Quetiapine Versus Risperidone on Sexual FunctioningJournal of Clinical Psychopharmacology, 2004
- Suppressed Prolactin Response to Dynorphin A1–13 in Methadone-Maintained Versus Control SubjectsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- The Effect of Fluvoxamine on Serum Prolactin and Serum Sodium ConcentrationsJournal of Clinical Psychopharmacology, 1997
- Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in menClinical Endocrinology, 1996
- Effects of Five Days Verapamil Administration on Serum GH and PRL LevelsHormone and Metabolic Research, 1985
- Effects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic responses to tryptophan in depressed patientsLife Sciences, 1985
- Morphine inhibits cortisol and stimulates prolactin secretion in manPsychoneuroendocrinology, 1984
- Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neuronsLife Sciences, 1979
- Interaction between opiates and hypothalamic dopamine on prolactin releaseLife Sciences, 1979
- Effect of Chronic Metoclopramide Therapy on Serum Pituitary Hormone ConcentrationsHormone Research, 1979